1. 2022-RA-1064-ESGO Unresectable peritoneal metastases from stage III ovarian cancer treated with bidirectional approach of Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) and systemic chemotherapy may lead to secondary complete cytoreductive surgery: a pilot study. (20th October 2022) Authors: Kefleyesus, Amaniel; Kepenekian, Vahan; Bonnefoy, Isabelle; Peron, Julien; You, Benoit; Glehen, Olivier; Bakrin, Naoual Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2022-RA-1088-ESGO Chitinase response after 3 cycles of chemotherapy as a promising marker of chemosensitivity an ancillary analysis of the GINECO-ENGOT EWOC-1 trial. (20th October 2022) Authors: Chikh, Karim; Cuerq, Charlotte; Valero, Marie; Colomban, Olivier; Savoye, Aude-Marie; Berton, Dominique; Stefani, Laëtitia; Fabbro, Michel; Blonz, Cyriac; Tredan, Olivier; Noblecourt, Margot; Cojocarasu, Oana; Mollon-Grange, Delphine; Barlesi, Fabrice; Pujade-Lauraine, Eric; Freyer, Gilles; You, ... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2022-RA-966-ESGO Tolerance of intraperitoneal (IP) nivolumab after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients (pts) with relapse advanced ovarian carcinoma: a phase I study with expansion cohort (ICONIC). (20th October 2022) Authors: Corbaux, Pauline; You, Benoit; Bakrin, Naoual; Glehen, Olivier; Freyer, Gilles Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A systematic review of adverse events in randomized trials assessing immune checkpoint inhibitors. Issue 3 (4th February 2019) Authors: Arnaud‐Coffin, Patrick; Maillet, Denis; Gan, Hui K.; Stelmes, Jean‐Jacques; You, Benoit; Dalle, Stephane; Péron, Julien Journal: International journal of cancer Issue: Volume 145:Issue 3(2019) Page Start: 639 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Actionable molecular alterations in advanced gynaecologic malignancies: updated results from the ProfiLER programme. (September 2019) Authors: Varnier, Romain; Le Saux, Olivia; Chabaud, Sylvie; Garin, Gwenaëlle; Sohier, Emilie; Wang, Qing; Paindavoine, Sandrine; Pérol, David; Baudet, Christian; Attignon, Valéry; Pissaloux, Daniel; Heudel, Pierre; You, Benoit; Leyronnas, Cécile; Collard, Olivier; Trédan, Olivier; Bonnin, Nathalie; Long, ... Journal: European journal of cancer Issue: Volume 118(2019) Page Start: 156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Aggregated adverse-events outcomes in oncology phase III reports: A systematic review. (January 2016) Authors: Maillet, Denis; Gan, Hui K.; Blay, Jean-Yves; You, Benoit; Péron, Julien Journal: European journal of cancer Issue: Volume 52(2016) Page Start: 26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Appendiceal tumors and pseudomyxoma peritonei: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (RENAPE, RENAPATH, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR). Issue 1 (January 2022) Authors: Delhorme, Jean-Baptiste; Villeneuve, Laurent; Bouché, Olivier; Averous, Gerlinde; Dohan, Anthony; Gornet, Jean-Marc; You, Benoit; Bibeau, Frédéric; Dartigues, Peggy; Eveno, Clarisse; Fontaine, Juliette; Kepenekian, Vahan; Pocard, Marc; Rousset, Pascal; Quenet, Francois; Mariani, Pascale; Glehen, ... Journal: Digestive and liver disease Issue: Volume 54:Issue 1(2022) Page Start: 30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Bevacizumab for Newly Diagnosed Ovarian Cancers: Best Candidates Among High-Risk Disease Patients (ICON-7). Issue 3 (4th April 2020) Authors: Colomban, Olivier; Tod, Michel; Peron, Julien; Perren, Timothy J; Leary, Alexandra; Cook, Adrian D; Sajous, Christophe; Freyer, Gilles; You, Benoit Journal: JNCI cancer spectrum Issue: Volume 4:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. CA-125 KELIM as a Potential Complementary Tool for Predicting Veliparib Benefit: An Exploratory Analysis From the VELIA/GOG-3005 Study. Issue 1 (1st January 2023) Authors: You, Benoit; Sehgal, Vasudha; Hosmane, Balakrishna; Huang, Xin; Ansell, Peter J.; Dinh, Minh H.; Bell-McGuinn, Katherine; Luo, Xizhi; Fleming, Gini F.; Friedlander, Michael; Bookman, Michael A.; Moore, Kathleen N.; Steffensen, Karina D.; Coleman, Robert L.; Swisher, Elizabeth M. Journal: Journal of clinical oncology Issue: Volume 41:Issue 1(2023) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Changes in the Use of Comprehensive Geriatric Assessment in Clinical Trials for Older Patients with Cancer over Time. (1st February 2019) Authors: Le Saux, Olivia; Falandry, Claire; Gan, Hui K.; You, Benoit; Freyer, Gilles; Péron, Julien Journal: Oncologist Issue: Volume 24:Number 8(2019) Page Start: 1089 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗